H.R. 9598 · 118th Congress (2023–2025)
Office of National Drug Control Policy Reauthorization Act of 2024
This bill reauthorizes through FY2031 the Office of National Drug Control Policy and related grants, programs, and initiatives such as
- the High Intensity Drug Trafficking Areas program,
- the Drug-Free Communities program,
- the Drug Court Training and Technical Assistance program, and
- the National Community Anti-Drug Coalition Institute.
Show official title
To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
80 days after it was introduced
This is H.R. 9598’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. James Comer (R-KY-1)
- Cosponsors
5 cosponsors
5 original · 0 later
- Rep. John S. Duarte (R-CA-13)· Original · Sep 16, 2024
- Res. Comm. Jenniffer González-Colón (R-PR)· Original · Sep 16, 2024
- Rep. Jerrold Nadler (D-NY-12)· Original · Sep 16, 2024
- Del. Stacey E. Plaskett (D-VI)· Original · Sep 16, 2024
- Rep. Jamie Raskin (D-MD-8)· Original · Sep 16, 2024
- Policy area
- Crime and Law Enforcement
- Subjects
- Border security and unlawful immigration
- Caribbean area
- Congressional oversight
- Customs enforcement
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Executive Office of the President
- Executive agency funding and structure
7 more
- Law enforcement administration and funding
- Lawyers and legal services
- Mental health
- Organized crime
- Puerto Rico
- Smuggling and trafficking
- Virgin Islands
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
▸ 3 committee actions · Sep 16, 2024 – Sep 18, 2024
Referred to committee
Referred to the Committee on Oversight and Accountability, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Markup session held
Committee Consideration and Mark-up Session Held
Sources
- Congress.gov action
- House committee actions
Ordered reported
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 38 - 0.
Sources
- Congress.gov action
- House committee actions
Passed House
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 399 - 1 (Roll no. 485). (text: 12/4/2024 CR H6319-6322)
The House passed the bill as amended.
Document: Engrossed in House
Sources
- Congress.gov action
- House Roll Call Vote 485
- House floor actions
- Latest
Referred to committee
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Sources
- Congress.gov action
- Senate
Expired
Passed House → Referred to Senate Judiciary → No further action before the 118th Congress ended.
Roll-call votes
Committees
Sep 18, 2024 · Markup
Floor record
i
Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.
Dec 4, 2024 · House · Considered under suspension of the rulesCongressional Record H6319–H6324
Office of National Drug Control Policy Reauthorization Act of 2024
Dec 5, 2024 · House · Considered as unfinished businessCongressional Record H6395
Announcement by the Speaker Pro Tempore
Dec 5, 2024 · House · Considered as unfinished businessCongressional Record H6396
Office of National Drug Control Policy Reauthorization Act of 2024
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
Titles (2)
Office of National Drug Control Policy Reauthorization Act of 2024
Short title, Display title · Referred in Senate, Engrossed in House, Introduced in House
To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes.
Official title · Introduced in House